128 related articles for article (PubMed ID: 7665066)
21. Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients.
Fischer MA; Morris CA; Winkelmayer WC; Avorn J
Arch Intern Med; 2007 Apr; 167(8):840-6. PubMed ID: 17452549
[TBL] [Abstract][Full Text] [Related]
22. [Erythropoietin--therapeutic option in chronic polyarthritis-induced anemia].
Rave O; Wienands K
Z Rheumatol; 1995; 54(1):50-5. PubMed ID: 7725810
[TBL] [Abstract][Full Text] [Related]
23. Parenteral iron therapy in obstetrics: 8 years experience with iron-sucrose complex.
Perewusnyk G; Huch R; Huch A; Breymann C
Br J Nutr; 2002 Jul; 88(1):3-10. PubMed ID: 12117422
[TBL] [Abstract][Full Text] [Related]
24. [Iron therapy of anemia in pregnancy and puerperium].
Nietfeld C
Fortschr Med; 1981 Sep; 99(34):1370-2. PubMed ID: 7286883
[TBL] [Abstract][Full Text] [Related]
25. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
Maruyama Y; Nakayama M; Yoshimura K; Nakano H; Yamamoto H; Yokoyama K; Lindholm B
Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
[TBL] [Abstract][Full Text] [Related]
26. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
[TBL] [Abstract][Full Text] [Related]
27. Intravenous iron administration during the maintenance period in erythropoietin-treated hemodialysis patients: a simple and effective method.
Nurnuansuwan S; Leelahavanichkul A; Pansin P; Eiam-Ong S
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S184-8. PubMed ID: 16623026
[TBL] [Abstract][Full Text] [Related]
28. Prepartum anaemia: prevention and treatment.
Milman N
Ann Hematol; 2008 Dec; 87(12):949-59. PubMed ID: 18641987
[TBL] [Abstract][Full Text] [Related]
29. Recombinant human erythropoietin in the treatment of anemia of prematurity.
Chen JY; Wu TS; Chanlai SP
Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.
Henry DH; Abels RI
Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of adjuvant recombinant human erythropoietin and ferrous sulfate as treatment for iron deficiency anemia during the third trimester of pregnancy.
Sanchez-Gonzalez LR; Castro-Melendez SE; Angeles-Torres AC; Castro-Cortina N; Escobar-Valencia A; Quiroga-Garza A
Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():32-6. PubMed ID: 27566219
[TBL] [Abstract][Full Text] [Related]
32. [Effect of iron supplementation among pregnant women at mother-and-baby clinic of Sidi Bel Abbès, West Algeria].
Moulessehoul S; Demmouche A; Chafi Y; Benali M
Sante; 2004; 14(1):21-9. PubMed ID: 15217741
[TBL] [Abstract][Full Text] [Related]
33. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
Toblli JE; Lombraña A; Duarte P; Di Gennaro F
J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
35. Intravenous versus oral iron therapy for postpartum anaemia.
Jatoth P; Coundjidapadam CS
BJOG; 2007 May; 114(5):655; author reply 655-6. PubMed ID: 17439582
[No Abstract] [Full Text] [Related]
36. ITDI is the preferred treatment for iron supplementation in rHuEpo-treated anemic PD patients.
Ahsan N
Adv Perit Dial; 1998; 14():228-31. PubMed ID: 10649730
[TBL] [Abstract][Full Text] [Related]
37. Supplementing iron intravenously in pregnancy. A way to avoid blood transfusions.
Hallak M; Sharon AS; Diukman R; Auslender R; Abramovici H
J Reprod Med; 1997 Feb; 42(2):99-103. PubMed ID: 9058345
[TBL] [Abstract][Full Text] [Related]
38. Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity.
Bovy C; Gothot A; Delanaye P; Warling X; Krzesinski JM; Beguin Y
Nephrol Dial Transplant; 2007 Apr; 22(4):1156-62. PubMed ID: 17237481
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of oral and intravenous iron therapy in haemodialysis patients.
Jenq CC; Tian YC; Wu HH; Hsu PY; Huang JY; Chen YC; Fang JT; Yang CW
Int J Clin Pract; 2008 Mar; 62(3):416-22. PubMed ID: 17511797
[TBL] [Abstract][Full Text] [Related]
40. Infusion of total dose iron versus oral iron supplementation in ambulatory peritoneal dialysis patients: a prospective, cross-over trial.
Ahsan N
Adv Perit Dial; 2000; 16():80-4. PubMed ID: 11045266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
